Cerebrospinal fluid cytology in a case of epithelioid glioblastoma

Epithelioid glioblastoma (eGB) is a rare GB subtype exhibiting characteristic morphology and genetic alterations. The efficacy of BRAF and MEK‐1/2 inhibitors is demonstrated in eGB treatment, and therefore, considering eGB is important to enhance patient care and prognosis.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cytopathology (Oxford) 2024-11, Vol.35 (6), p.780-785
Hauptverfasser:	Homma, Taku, Suzuki, Tomonari, Kato, Tomomi, Shirahata, Mituaki, Mishima, Kazuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	atypical teratoid/rhabdoid tumour Brain Neoplasms - cerebrospinal fluid Brain Neoplasms - diagnosis Brain Neoplasms - pathology brain tumour Cerebrospinal fluid cerebrospinal fluid cytology Cytodiagnosis Cytology Epithelioid Cells - pathology epithelioid glioblastoma Glioblastoma Glioblastoma - cerebrospinal fluid Glioblastoma - diagnosis Glioblastoma - pathology Humans Male Middle Aged Physical characteristics Proto-Oncogene Proteins B-raf - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Epithelioid glioblastoma (eGB) is a rare GB subtype exhibiting characteristic morphology and genetic alterations. The efficacy of BRAF and MEK‐1/2 inhibitors is demonstrated in eGB treatment, and therefore, considering eGB is important to enhance patient care and prognosis.
ISSN:	0956-5507 1365-2303 1365-2303
DOI:	10.1111/cyt.13436